While the Centre has mandated the establishment of chest clinics in government health facilities and medical colleges to ...

Under the terms of the agreements, if GSK elects to progress into a further collaboration, ProFound and Quotient will advance their respective programs through key preclinical activities, after which ...

COPD, which includes chronic bronchitis and emphysema, is progressive, meaning it gets worse over time without treatment.

Billings Clinic’s residency programs are training new doctors in the communities that need them most, countering national ...

On November 13, 2025, thirteen Southern Regional Technical College (SRTC) Respiratory Care graduates were honored during a ...

At 50 years old, my health began to deteriorate in ways no one could explain. For nearly two decades, I searched for answers. It wasn’t until I was 69 that I finally learned the truth: I have cystic ...

A deep divide has emerged between Celtic’s board and its fanbase, fueled by malevolent actions from the boardroom. Dawn raids ...

Storms of any kind can disturb particulates in the air, temporarily increasing circulating toxicants like mycotoxins. With mycotoxins, the dose makes the poison — rapid, high volume exposure causing ...

ProFound Therapeutics will use its proteomic technology and Quotient Therapeutics its genomics platform to uncover respiratory and liver disease treatments.

Agreements will utilize ProFound's and Quotient's platform technologies to discover and validate novel treatments for respiratory and liver diseases.

This novel, low-dose advancement in digital X-ray enables visualization of anatomy in motion with a simple acquisition. The seven RSNA 2025 presentations further demonstrate the clinical value of DDR ...

A persistent cough ranks among the most frequent and obvious signs of the condition, though it's particularly a cough that ...